Skip to content
777 Sourcing.

Capability

peptide drug development

Suppliers
2
States & provinces
2
Countries
1

2 peptide drug development suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure. It develops regenerative peptide drugs, led by TP508 (Rusalatide acetate, Chrysalin), to restore vascular function and activate stem cells. Incorporated in Delaware in 2012, it is based in Galveston, Texas.

clinical trialsdrug formulation/CMC developmentpreclinical studies

Creative Bio-Peptides Inc. (CBP) is an early-stage biopharmaceutical company based in Rockville, MD, started in late 2017. It develops novel oral peptide immunotherapies, including receptor-active peptides (RAPs) such as lead compound RAP-103, for neurodegeneration, brain injuries, chronic pain, and substance use disorders.

oral peptide therapeuticspreclinical research

Related capabilities

Other processes offered by the shops that list peptide drug development.

Browse all capabilities